Chemocentryx (CCXI) Shareholder Baker Bros Advisors LP Cut Stake by $2.07 Million; Wunderlich Securities Upped Jpmorgan Chase & Co Com (JPM) Position

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Baker Bros Advisors Lp decreased its stake in Chemocentryx Inc. (CCXI) by 50% based on its latest 2018Q4 regulatory filing with the SEC. Baker Bros Advisors Lp sold 207,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 207,029 shares of the health care company at the end of 2018Q4, valued at $2.26M, down from 414,029 at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Chemocentryx Inc. for a number of months, seems to be less bullish one the $693.09M market cap company. The stock decreased 0.33% or $0.04 during the last trading session, reaching $11.94. About 294,526 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 15, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c

Wunderlich Securities Inc increased its stake in Jpmorgan Chase & Co Com (JPM) by 24.84% based on its latest 2018Q4 regulatory filing with the SEC. Wunderlich Securities Inc bought 3,191 shares as the company’s stock declined 6.08% while stock markets rallied. The institutional investor held 16,039 shares of the major banks company at the end of 2018Q4, valued at $1.57 million, up from 12,848 at the end of the previous reported quarter. Wunderlich Securities Inc who had been investing in Jpmorgan Chase & Co Com for a number of months, seems to be bullish on the $357.82B market cap company. The stock increased 0.79% or $0.87 during the last trading session, reaching $110.32. About 10.00 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has declined 8.15% since May 15, 2018 and is downtrending. It has underperformed by 12.52% the S&P500. Some Historical JPM News: 12/03/2018 – KCS’ Mike Upchurch to Address the J.P. Morgan 2018 Aviation, Transportation and Industrials Conference; 10/04/2018 – CONSOLIDATED EDISON INC ED.N : JP MORGAN RAISES TARGET PRICE TO $78 FROM $75; 16/04/2018 – JPMorgan Diversified Alternatives ETF Above 50-D-MA: Technicals; 16/05/2018 – JP Morgan chairman Jamie Dimon has called bitcoin a “fraud,” and Vanguard CEO Tim Buckley told CNBC in an interview: “You will never see a fund from Vanguard on bitcoin.”; 18/04/2018 – IMERYS WORKING WITH JPMORGAN AND ROTHSCHILD ON SALE OF ITS TILES BUSINESS; 31/05/2018 – OCADO GROUP PLC OCDO.L : JP MORGAN RAISES TARGET PRICE TO 871P FROM 505P; 11/04/2018 – COMPAGNIE FINANCIERE RICHEMONT SA CFR.S : JP MORGAN RAISES TARGET PRICE TO SFR 87 FROM SFR 84; 07/05/2018 – Medtronic Hires JPMorgan Analyst to Focus on Shareholder Value; 13/03/2018 – AIR CANADA CFO ENDS PRESENTATION AT JP MORGAN CONFERENCE; 24/04/2018 – KONINKLIJKE PHILIPS NV PHG.AS : JP MORGAN RAISES TARGET PRICE TO 36.7 EUROS FROM 35.6 EUROS

Wunderlich Securities Inc, which manages about $1.08 billion and $476.87M US Long portfolio, decreased its stake in First Tr Exchange (FPE) by 30,500 shares to 73,505 shares, valued at $1.32 million in 2018Q4, according to the filing. It also reduced its holding in Facebook Inc (NASDAQ:FB) by 4,075 shares in the quarter, leaving it with 30,307 shares, and cut its stake in Alps Trust Etf Alerian Mlp (AMLP).

Since January 13, 2019, it had 3 insider buys, and 5 sales for $2.79 million activity. The insider Beer Lori A sold $1.40M. $1.22M worth of JPMorgan Chase & Co. (NYSE:JPM) was sold by Petno Douglas B on Tuesday, January 29. 5,831 shares were sold by BACON ASHLEY, worth $599,304. Shares for $317,310 were sold by Friedman Stacey. On Tuesday, April 16 the insider HOBSON MELLODY L bought $2.00 million. On Tuesday, January 29 Scher Peter sold $1.96M worth of JPMorgan Chase & Co. (NYSE:JPM) or 18,679 shares.

Investors sentiment increased to 1 in 2018 Q4. Its up 0.05, from 0.95 in 2018Q3. It is positive, as 71 investors sold JPM shares while 735 reduced holdings. 135 funds opened positions while 667 raised stakes. 2.33 billion shares or 0.45% more from 2.32 billion shares in 2018Q3 were reported. Mastrapasqua Asset Mngmt Inc reported 6,301 shares or 0.14% of all its holdings. Segment Wealth Limited Liability Company reported 1.25% in JPMorgan Chase & Co. (NYSE:JPM). Panagora Asset Management invested 1.32% in JPMorgan Chase & Co. (NYSE:JPM). Cna holds 2.81% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 133,264 shares. Westchester Cap Mngmt Inc owns 83,608 shares. Lincluden Management holds 0.39% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 52,186 shares. First Long Island Invsts Ltd Com stated it has 5,572 shares or 0.08% of all its holdings. 128,031 were accumulated by Callahan Advsrs Limited Com. Macroview Invest Mngmt Ltd Liability Com reported 0.01% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Farmers Trust owns 97,543 shares. Holt Cap Advisors Limited Company Dba Holt Cap Prtn Limited Partnership accumulated 0.09% or 2,803 shares. D E Shaw And Com Incorporated accumulated 678,019 shares. Hbk Investments Limited Partnership holds 65,810 shares or 0.09% of its portfolio. Choate Invest Advsrs invested in 0.63% or 100,464 shares. First Manhattan Company holds 0.21% in JPMorgan Chase & Co. (NYSE:JPM) or 339,065 shares.

More notable recent JPMorgan Chase & Co. (NYSE:JPM) news were published by: Seekingalpha.com which released: “Why JPMorgan Is The Strongest American Bank – Seeking Alpha” on April 29, 2019, also Fool.com with their article: “Microsoft and JPMorgan Chase Team Up on Blockchain Efforts – The Motley Fool” published on May 03, 2019, Seekingalpha.com published: “J.P. Morgan names new CFO; Lake moves to top consumer lending role – Seeking Alpha” on April 17, 2019. More interesting news about JPMorgan Chase & Co. (NYSE:JPM) were released by: Investorideas.com and their article: “CryptoCorner: Serena Williams Newly Announced VC Firm Invests in Coinbase, JPMorgan (NYSE: JPM) Expanding Blockchain Tech and Payment Processor Moon Allows Amazon (NASDAQ: AMZN) – InvestorIdeas.com” published on April 22, 2019 as well as Benzinga.com‘s news article titled: “J P Morgan Chase & Co (NYSE:JPM) – Hot Commodities: Hemp State Of The States And CBD Mania – Benzinga” with publication date: April 25, 2019.

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It is negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Maryland-based Adams Diversified Equity Fund has invested 0.03% in ChemoCentryx, Inc. (NASDAQ:CCXI). 10,418 were accumulated by Credit Suisse Ag. Baker Bros Advsrs LP reported 207,029 shares. Clarivest Asset Limited Liability Corporation invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). California State Teachers Retirement Systems holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 35,245 shares. Charles Schwab Inv accumulated 49,177 shares. Bnp Paribas Arbitrage Sa accumulated 10 shares. Panagora Asset Mngmt holds 0.02% or 324,223 shares in its portfolio. Prelude Mgmt Lc invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Qs Limited Liability Corp stated it has 643 shares or 0% of all its holdings. Acadian Asset Limited Liability Co reported 818,489 shares. Smith Asset Mngmt Grp Inc Lp holds 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 22,897 shares. Retail Bank Of Montreal Can reported 0% stake. Citigroup owns 4,073 shares for 0% of their portfolio. Deutsche Retail Bank Ag reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI).

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates – Nasdaq” on May 06, 2019, also Globenewswire.com with their article: “ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights – GlobeNewswire” published on May 06, 2019, Seekingalpha.com published: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” on May 06, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx terminates previously announced common stock offering – Seeking Alpha” published on September 28, 2018 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: March 12, 2019.

Since January 7, 2019, it had 0 insider buys, and 5 sales for $1.38 million activity. 13,203 shares valued at $158,790 were sold by Cappel Markus J. on Monday, January 7. The insider KANAYA SUSAN M sold 37,893 shares worth $457,747.

Baker Bros Advisors Lp, which manages about $8.20 billion and $12.21B US Long portfolio, upped its stake in Amarin Corporation Plc (NASDAQ:AMRN) by 8.52M shares to 42.59M shares, valued at $579.69 million in 2018Q4, according to the filing. It also increased its holding in Clementia Pharmaceuticals Inc. by 1.79 million shares in the quarter, for a total of 3.72 million shares, and has risen its stake in Acadia Pharmaceuticals Inc. (NASDAQ:ACAD).

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *